ArticleScientific reports2026
Early quantitative stress-perfusion cardiac magnetic resonance reveals perfusion abnormalities consistent with coronary microvascular dysfunction in MINOCA patients with otherwise normal cardiac magnetic resonance findings.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary microvascular dysfunction (CMD) is a proposed contributor to myocardial infarction with non-obstructive coronary arteries (MINOCA), but the value of early quantitative stress-perfusion CMR (Q-CMR) in this setting is not fully established. We aimed to determine the prevalence of quantitative perfusion abnormalities consistent with CMD using Q-CMR in patients with a working diagnosis of MINOCA and otherwise normal conventional CMR findings. Of 46 consecutive MINOCA patients referred for CMR between 2021 and 2024, 23 had normal findings on conventional CMR at rest and were included. They were compared with age- and sex-matched healthy controls without coronary artery disease, confirmed by coronary CT angiography. All participants underwent dual-sequence first-pass perfusion CMR at rest and during regadenoson stress. Fully automated quantitative perfusion analysis was used to quantify myocardial blood flow (MBF) and myocardial perfusion reserve (MPR). CMR at rest was considered normal in the absence of edema, late gadolinium enhancement, or other structural abnormalities. The MINOCA patients (mean age 63 ± 10 years, 61% female) were scanned a median of 15 days (IQR 10-37) after admission. Compared with controls, they had lower MPR (1.88 ± 0.59 vs. 2.30 ± 0.55; p = 0.013) and lower stress MBF (2.56 ± 0.81 vs. 2.96 ± 0.53 mL/g/min; p = 0.044), while rest MBF was similar. 43% of MINOCA patients had quantitative perfusion findings consistent with CMD according to previously proposed CMR thresholds, compared with none of the controls. In conclusion, early Q-CMR identifies reduced stress MBF and MPR in MINOCA patients with otherwise normal conventional CMR findings and reveals perfusion abnormalities consistent with CMD in nearly half of these patients, suggesting that microvascular dysfunction may contribute to myocardial injury in a subset of MINOCA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.